AAO: Alcon virtual booth spotlights latest studies, retina product offerings

Video
Conference|AAO

Josh Anderson, head of U.S. retina sales and marketing for Alcon, outlines what attendees will learn including product updates, new technologies, and practice management materials for ophthalmologists and their patients during the COVID-19 pandemic.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected


      Josh Anderson, head of U.S. retina sales and marketing forAlcon, outlines what attendees will learn including product updates, new technologies, and practice management materials for ophthalmologists and their patients during the time of the coronavirus disease 2019 pandemic.

      Retina surgeons, especially, will be interested in the dual-blade vitrectomy probe (Hypervit) as well as a refinement to Grieshaber instrumentation.

      Newsletter

      Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

      Subscribe Now!
      Recent Videos
      Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
      Modern monitoring strategies remove major barriers to retina care
      Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
      Tyson Brunstetter, OD, PhD, shares key takeaways from his keynote at the International SPECTRALIS Symposium
      Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
      ARVO 2025: Ocular and systemic mitochondrial diseases may be key to dementia diagnosis
      Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
      ARVO 2025: Alfredo Sadun, MD, PhD, says "later is better" for some LHON interventions
      At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
      ARVO 2025: Nitish Mehta, MD, provides real-world insights from aflibercept 8 mg for treatment-naive diabetic macular oedema
      ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
      ARVO 2025: Anat Loewenstein, MD, and colleagues on meeting needs of patients with diabetic retinopathy
      A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
      A panel discussion on extended treatment intervals in retinal therapy breaks the mold at COPHy 2025
      Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
      How embracing opposition sends clinicians home from COPHy with more useful takeaways
      Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
      Angiogenesis 2025: The global forecast for AI-driven home OCT
      Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
      Charles Wykoff, MD, PhD, presents on diabetic retinopathy and "the dream of reperfusion" at Floretina ICOOR 2024
      Related Content
      Concept image for telehealth, telemedicine, remote ophthalmology, retinal imaging and monitoring, hospital health system and community care collaboration. Image credit: ©Melinda Nagy – stock.adobe.com

      How remote retinal imaging raises the bar across service, research and education

      Hattie Hayes;Baljean Dhillon, FRCPS, FRCS, FRCOphth, FRCPE
      June 14th 2025
      Article

      Prof Baljean Dhillon advocated for remote practices and provided advice for implementation at the International SPECTRALIS Symposium

      PHOTON Results and Their Relation to DME Patients in Your Practice

      PHOTON Results and Their Relation to DME Patients in Your Practice

      July 25th 2024
      Podcast

      John Kitchens, MD, is joined by Diana Do, MD, to discuss the PHOTON trial results and their relation to patients with diabetic macular oedema in clinical practice.

      Scientists work in a lab, looking at microscopes while data is superimposed over the top of the photo. Concept image for clinical trial research and structural functional endpoints in ophthalmology. Image credit: ©metamorworks – stock.adobe.com

      Imaging the ellipsoid zone line could change the global approach to clinical trials

      Hattie Hayes;Robyn Guymer, AM, MBBS, PhD, FRANZCO, FAHMS
      June 13th 2025
      Article

      Robyn Guymer, AM, MBBS, PhD, FRANZCO, FAHMS, presented two studies involving the EZ line at this year’s International SPECTRALIS Symposium

      PULSAR Results and Their Relation to nAMD Patients in Your Practice

      PULSAR Results and Their Relation to nAMD Patients in Your Practice

      July 24th 2024
      Podcast

      John Kitchens, MD, is joined by David Brown, MD, to discuss the PULSAR study results and their relation to patients with neovascular age-related macular degeneration in clinical practice.

      Gereon Hüttmann, PhD, deputy head of the Institute of Biomedical Optics, University of Lübeck, Germany, presented on holographic optical coherence tomography (HOLO-OCT) at the International SPECTRALIS Symposium (ISS)

      Gereon Hüttmann, PhD, introduces holographic OCT to a new audience

      Hattie Hayes;Gereon Hüttmann, PhD
      June 13th 2025
      Article

      The new technology will be crucial to imaging retinal function in the future, Prof Hüttmann predicted at the International SPECTRALIS Symposium

      An elderly man and woman walk down a path in a sunny park with grass and trees. Concept image for NICOLA, The Northern Ireland Cohort for the Longitudinal Study of Ageing. Image credit: ©Ivica Drusany – stock.adobe.com

      Ruth Hogg, PhD, says NICOLA data emphasise the value of multicolor images

      Hattie Hayes;Ruth Hogg, PhD
      June 13th 2025
      Article

      Prof Hogg presented a wide breadth of research at the International SPECTRALIS Symposium

      © 2025 MJH Life Sciences

      All rights reserved.